Antilymphoma Treatments Given Subsequent to Yttrium 90 Ibritumomab Tiuxetan Are Feasible in Patients with Progressive Non-Hodgkin's Lymphoma: A Review of the Literature
Titel:
Antilymphoma Treatments Given Subsequent to Yttrium 90 Ibritumomab Tiuxetan Are Feasible in Patients with Progressive Non-Hodgkin's Lymphoma: A Review of the Literature
Auteur:
Ansell, Stephen M. Schilder, Russell J. Pieslor, Peter C. Gordon, Leo I. Emmanouilides, Christos Vo, Katie Czuczman, Myron S. Witzig, Thomas E. Theuer, Charles Molina, Arturo